Clinical outcomes in patients with atrial fibrillation treated with DOACs in a specialized anticoagulation center: Critical appraisal of real-world data

AIMS: Direct oral anticoagulants (DOAC) are progressively replacing vitamin K antagonists in the prevention of thromboembolism in patients with atrial fibrillation. However, their real-world clinical outcomes appear to be contradictory, with some studies reporting fewer and others reporting higher c...

Descripción completa

Detalles Bibliográficos
Autores principales: Moret, Carla, Acosta-Isaac, René, Mojal, Sergi, Corrochano, Mariana, Jiménez, Blanca, Plaza, Melania, Souto, Juan Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955586/
https://www.ncbi.nlm.nih.gov/pubmed/36827286
http://dx.doi.org/10.1371/journal.pone.0279297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955586/
https://www.ncbi.nlm.nih.gov/pubmed/36827286
http://dx.doi.org/10.1371/journal.pone.0279297

Ejemplares similares